

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 7.32319892 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 7.32319892 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.07705649 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.99310576 |
| 5 | L-amino acid import (GO:0043092) | 5.66818717 |
| 6 | amino acid import (GO:0043090) | 5.35916994 |
| 7 | myelination (GO:0042552) | 5.13895144 |
| 8 | ensheathment of neurons (GO:0007272) | 5.10526763 |
| 9 | axon ensheathment (GO:0008366) | 5.10526763 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.92857997 |
| 11 | synaptic vesicle maturation (GO:0016188) | 4.50875803 |
| 12 | potassium ion homeostasis (GO:0055075) | 4.44956536 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.43471490 |
| 14 | activated T cell proliferation (GO:0050798) | 4.17319393 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.16212200 |
| 16 | response to methylmercury (GO:0051597) | 4.08064597 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.00853476 |
| 18 | transmission of nerve impulse (GO:0019226) | 3.96790901 |
| 19 | glycine transport (GO:0015816) | 3.90411530 |
| 20 | neuronal ion channel clustering (GO:0045161) | 3.87255610 |
| 21 | exploration behavior (GO:0035640) | 3.86439098 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77728283 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.74576383 |
| 24 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.74534620 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.73015710 |
| 26 | positive regulation of dendritic spine development (GO:0060999) | 3.71091996 |
| 27 | activation of protein kinase A activity (GO:0034199) | 3.70175396 |
| 28 | fatty acid elongation (GO:0030497) | 3.68506962 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 3.67392151 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65891526 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.62294303 |
| 32 | adult walking behavior (GO:0007628) | 3.60254506 |
| 33 | synaptic vesicle exocytosis (GO:0016079) | 3.57571532 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57357228 |
| 35 | presynaptic membrane organization (GO:0097090) | 3.57117311 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.57024473 |
| 37 | dendrite morphogenesis (GO:0048813) | 3.54918614 |
| 38 | negative regulation of neurotransmitter transport (GO:0051589) | 3.51464335 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.50702380 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 3.50325942 |
| 41 | vocalization behavior (GO:0071625) | 3.49993055 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.47125626 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.44893808 |
| 44 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.42022675 |
| 45 | glutamate secretion (GO:0014047) | 3.41759662 |
| 46 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.41692612 |
| 47 | regulation of ARF protein signal transduction (GO:0032012) | 3.40139669 |
| 48 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39885018 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.39004491 |
| 50 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.38031806 |
| 51 | cellular sodium ion homeostasis (GO:0006883) | 3.37309580 |
| 52 | regulation of neurotransmitter levels (GO:0001505) | 3.36529680 |
| 53 | neuron recognition (GO:0008038) | 3.36280758 |
| 54 | oligodendrocyte differentiation (GO:0048709) | 3.36182437 |
| 55 | peripheral nervous system axon ensheathment (GO:0032292) | 3.34501853 |
| 56 | myelination in peripheral nervous system (GO:0022011) | 3.34501853 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 3.32617035 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.31971636 |
| 59 | negative regulation of inclusion body assembly (GO:0090084) | 3.29798843 |
| 60 | substantia nigra development (GO:0021762) | 3.27348366 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.24866828 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.24863316 |
| 63 | regulation of collateral sprouting (GO:0048670) | 3.21057851 |
| 64 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.20661802 |
| 65 | neurotransmitter secretion (GO:0007269) | 3.19435264 |
| 66 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.15826149 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.14819241 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 3.13107474 |
| 69 | glycosphingolipid biosynthetic process (GO:0006688) | 3.11410334 |
| 70 | acidic amino acid transport (GO:0015800) | 3.11263760 |
| 71 | L-glutamate transport (GO:0015813) | 3.10983870 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.10427620 |
| 73 | myelin maintenance (GO:0043217) | 3.10315034 |
| 74 | negative regulation of axonogenesis (GO:0050771) | 3.08936170 |
| 75 | neuron-neuron synaptic transmission (GO:0007270) | 3.08622150 |
| 76 | protein localization to synapse (GO:0035418) | 3.07124068 |
| 77 | cell communication by electrical coupling (GO:0010644) | 3.06926728 |
| 78 | synaptic transmission, glutamatergic (GO:0035249) | 3.05962856 |
| 79 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05831984 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 3.04774524 |
| 81 | regulation of dendritic spine development (GO:0060998) | 3.04754962 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.03415515 |
| 83 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.02859346 |
| 84 | C4-dicarboxylate transport (GO:0015740) | 3.02735172 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 3.02394952 |
| 86 | positive regulation of neurological system process (GO:0031646) | 3.01743614 |
| 87 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.00113503 |
| 88 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99313528 |
| 89 | regulation of neurotransmitter secretion (GO:0046928) | 2.99218961 |
| 90 | negative regulation of axon extension (GO:0030517) | 2.98888799 |
| 91 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97876216 |
| 92 | axonal fasciculation (GO:0007413) | 2.96961845 |
| 93 | phosphorelay signal transduction system (GO:0000160) | 2.96208594 |
| 94 | cellular response to epinephrine stimulus (GO:0071872) | 2.93897953 |
| 95 | one-carbon compound transport (GO:0019755) | 2.93746332 |
| 96 | cerebellar granule cell differentiation (GO:0021707) | 2.93718831 |
| 97 | membrane hyperpolarization (GO:0060081) | 2.90953598 |
| 98 | glycerophospholipid catabolic process (GO:0046475) | 2.90662138 |
| 99 | regulation of synapse maturation (GO:0090128) | 2.90261556 |
| 100 | neurotransmitter transport (GO:0006836) | 2.88758932 |
| 101 | cellular potassium ion homeostasis (GO:0030007) | 2.87776927 |
| 102 | potassium ion import (GO:0010107) | 2.87574061 |
| 103 | regulation of synapse structural plasticity (GO:0051823) | 2.87160450 |
| 104 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85666601 |
| 105 | prepulse inhibition (GO:0060134) | 2.85300804 |
| 106 | regulation of neurotransmitter transport (GO:0051588) | 2.85110511 |
| 107 | positive regulation of membrane potential (GO:0045838) | 2.85091212 |
| 108 | regulation of cell communication by electrical coupling (GO:0010649) | 2.84726461 |
| 109 | positive regulation of dendrite development (GO:1900006) | 2.84453902 |
| 110 | long-term memory (GO:0007616) | 2.84407009 |
| 111 | peripheral nervous system development (GO:0007422) | 2.83881055 |
| 112 | layer formation in cerebral cortex (GO:0021819) | 2.83837974 |
| 113 | response to auditory stimulus (GO:0010996) | 2.83733708 |
| 114 | astrocyte development (GO:0014002) | 2.83145034 |
| 115 | positive regulation of Rap GTPase activity (GO:0032854) | 2.82805317 |
| 116 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82348016 |
| 117 | mating behavior (GO:0007617) | 2.82207418 |
| 118 | dendritic spine organization (GO:0097061) | 2.82121117 |
| 119 | synaptic transmission (GO:0007268) | 2.81504894 |
| 120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.79531089 |
| 121 | chemosensory behavior (GO:0007635) | 2.79235440 |
| 122 | neuron remodeling (GO:0016322) | 2.78205716 |
| 123 | eye photoreceptor cell differentiation (GO:0001754) | 2.77688701 |
| 124 | photoreceptor cell differentiation (GO:0046530) | 2.77688701 |
| 125 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.77648714 |
| 126 | regulation of Rap GTPase activity (GO:0032317) | 2.76687370 |
| 127 | response to redox state (GO:0051775) | 2.76093772 |
| 128 | regulation of synaptic plasticity (GO:0048167) | 2.75112750 |
| 129 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.74485416 |
| 130 | establishment of mitochondrion localization (GO:0051654) | 2.74361196 |
| 131 | sodium ion export (GO:0071436) | 2.73845659 |
| 132 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.73264893 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.73133747 |
| 134 | response to epinephrine (GO:0071871) | 2.72631674 |
| 135 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.70907743 |
| 136 | auditory behavior (GO:0031223) | 2.65344253 |
| 137 | import into cell (GO:0098657) | 2.63225984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.17993325 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97673924 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94792755 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93939286 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78165027 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61201110 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61201110 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54350018 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51673057 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43438299 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41612504 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39662254 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.38576928 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36431706 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33022373 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30821152 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23321462 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22547893 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21969705 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12660765 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11594401 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10065917 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07218256 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77421779 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.71485251 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65817223 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64790883 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63458456 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62517808 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61163282 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54570195 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.53679083 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53465085 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52679550 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50881712 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49498090 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46351076 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46200214 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45853574 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45304001 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36259787 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33855776 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33192876 |
| 44 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.30360683 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29931395 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29815421 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29393758 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29229186 |
| 49 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24986987 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23057629 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21473387 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20761965 |
| 53 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19502438 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18268212 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17139306 |
| 56 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17121663 |
| 57 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15988320 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15738026 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15242276 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14388194 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14337872 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13594907 |
| 63 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11734399 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09105720 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08217741 |
| 66 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07603632 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07224388 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06427035 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05395603 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04926136 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03666858 |
| 72 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03614011 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02785794 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02577087 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01642650 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01291321 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00575306 |
| 78 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.99665654 |
| 79 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99307626 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98504571 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98385863 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98244424 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97464635 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97284208 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96681614 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95444800 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94653546 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 0.94483796 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94150385 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93794912 |
| 91 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93369411 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92791879 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92791879 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92289516 |
| 95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92098972 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91847242 |
| 97 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90705400 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90508917 |
| 99 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90488077 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90388907 |
| 101 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.90107013 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88299549 |
| 103 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88186401 |
| 104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88028546 |
| 105 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87814480 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87681208 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87252815 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87109117 |
| 109 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86493550 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86284869 |
| 111 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85810009 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85682021 |
| 113 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85379092 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84844593 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84578664 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84529868 |
| 117 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83635861 |
| 118 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83405658 |
| 119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82113580 |
| 120 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81860884 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81105332 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81105332 |
| 123 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.81045809 |
| 124 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80951992 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80905569 |
| 126 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80103984 |
| 127 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80066486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.82924808 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.81194512 |
| 3 | MP0000920_abnormal_myelination | 3.92672879 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.44671056 |
| 5 | MP0004270_analgesia | 3.42403861 |
| 6 | MP0002064_seizures | 3.19134305 |
| 7 | MP0009745_abnormal_behavioral_response | 3.03563520 |
| 8 | MP0001486_abnormal_startle_reflex | 2.99248641 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.95466844 |
| 10 | MP0002272_abnormal_nervous_system | 2.90679010 |
| 11 | MP0003690_abnormal_glial_cell | 2.82624582 |
| 12 | MP0009046_muscle_twitch | 2.75183669 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.62496328 |
| 14 | MP0002822_catalepsy | 2.59223932 |
| 15 | MP0004885_abnormal_endolymph | 2.50169013 |
| 16 | MP0004742_abnormal_vestibular_system | 2.49945335 |
| 17 | MP0003329_amyloid_beta_deposits | 2.44872510 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.35058991 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.34981491 |
| 20 | MP0004142_abnormal_muscle_tone | 2.16571659 |
| 21 | MP0000778_abnormal_nervous_system | 2.14607926 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.13733772 |
| 23 | MP0001529_abnormal_vocalization | 2.12732722 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.08739245 |
| 25 | MP0008569_lethality_at_weaning | 2.03583248 |
| 26 | MP0001905_abnormal_dopamine_level | 1.98333805 |
| 27 | MP0003634_abnormal_glial_cell | 1.97457957 |
| 28 | MP0001970_abnormal_pain_threshold | 1.79179808 |
| 29 | MP0000955_abnormal_spinal_cord | 1.78385114 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.78302017 |
| 31 | MP0005171_absent_coat_pigmentation | 1.77094069 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.69961858 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.67871838 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.65830076 |
| 35 | MP0003136_yellow_coat_color | 1.62526080 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.61351212 |
| 37 | MP0003632_abnormal_nervous_system | 1.59047388 |
| 38 | MP0005409_darkened_coat_color | 1.53788917 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.53596925 |
| 40 | MP0003633_abnormal_nervous_system | 1.51101698 |
| 41 | MP0002736_abnormal_nociception_after | 1.49735593 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.49706785 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.48822593 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.47802234 |
| 45 | MP0004924_abnormal_behavior | 1.47802234 |
| 46 | MP0003631_nervous_system_phenotype | 1.47344235 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.42977884 |
| 48 | MP0002229_neurodegeneration | 1.40978933 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.39944780 |
| 50 | MP0002184_abnormal_innervation | 1.39769727 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.29403518 |
| 52 | MP0004147_increased_porphyrin_level | 1.24344752 |
| 53 | MP0000604_amyloidosis | 1.22870073 |
| 54 | MP0000462_abnormal_digestive_system | 1.22649466 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.20749875 |
| 56 | MP0005410_abnormal_fertilization | 1.18415968 |
| 57 | MP0000566_synostosis | 1.16644928 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.15206433 |
| 59 | MP0003787_abnormal_imprinting | 1.13753241 |
| 60 | MP0001177_atelectasis | 1.13246505 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.12215028 |
| 62 | MP0004134_abnormal_chest_morphology | 1.11714963 |
| 63 | MP0004858_abnormal_nervous_system | 1.09512280 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.08897417 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.08274639 |
| 66 | MP0009780_abnormal_chondrocyte_physiolo | 1.06980137 |
| 67 | MP0002152_abnormal_brain_morphology | 1.04460915 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.01907705 |
| 69 | MP0002752_abnormal_somatic_nervous | 0.99035854 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.98292630 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 0.97787962 |
| 72 | MP0001984_abnormal_olfaction | 0.91761057 |
| 73 | MP0001502_abnormal_circadian_rhythm | 0.90612680 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.90188308 |
| 75 | MP0002090_abnormal_vision | 0.87483013 |
| 76 | MP0004130_abnormal_muscle_cell | 0.86667778 |
| 77 | MP0004043_abnormal_pH_regulation | 0.86523109 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.84342494 |
| 79 | MP0000747_muscle_weakness | 0.84129471 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.83723487 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.81899483 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.80959863 |
| 83 | MP0008874_decreased_physiological_sensi | 0.77965939 |
| 84 | MP0003075_altered_response_to | 0.77663718 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.77077859 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.75686185 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.73446476 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.72294810 |
| 89 | MP0006276_abnormal_autonomic_nervous | 0.69761944 |
| 90 | MP0001661_extended_life_span | 0.69485241 |
| 91 | MP0010678_abnormal_skin_adnexa | 0.69352479 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.69078549 |
| 93 | MP0003938_abnormal_ear_development | 0.67831721 |
| 94 | MP0000751_myopathy | 0.67746400 |
| 95 | MP0003045_fibrosis | 0.65635574 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65566483 |
| 97 | MP0001943_abnormal_respiration | 0.62874643 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.62674101 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.61484486 |
| 100 | MP0008872_abnormal_physiological_respon | 0.61126105 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.60450959 |
| 102 | MP0003283_abnormal_digestive_organ | 0.59315292 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.58955391 |
| 104 | MP0000383_abnormal_hair_follicle | 0.58681842 |
| 105 | MP0003866_abnormal_defecation | 0.56115116 |
| 106 | MP0005166_decreased_susceptibility_to | 0.55883056 |
| 107 | MP0005195_abnormal_posterior_eye | 0.55389263 |
| 108 | MP0000579_abnormal_nail_morphology | 0.54597445 |
| 109 | MP0004085_abnormal_heartbeat | 0.54024923 |
| 110 | MP0005535_abnormal_body_temperature | 0.52003251 |
| 111 | MP0003123_paternal_imprinting | 0.51970444 |
| 112 | MP0001664_abnormal_digestion | 0.51261706 |
| 113 | MP0003879_abnormal_hair_cell | 0.51170572 |
| 114 | MP0002082_postnatal_lethality | 0.50635223 |
| 115 | MP0010770_preweaning_lethality | 0.50635223 |
| 116 | MP0000026_abnormal_inner_ear | 0.50057156 |
| 117 | MP0003956_abnormal_body_size | 0.49139772 |
| 118 | MP0002249_abnormal_larynx_morphology | 0.48476419 |
| 119 | MP0005388_respiratory_system_phenotype | 0.47902306 |
| 120 | MP0002133_abnormal_respiratory_system | 0.47902306 |
| 121 | MP0003861_abnormal_nervous_system | 0.47428478 |
| 122 | MP0004133_heterotaxia | 0.46726334 |
| 123 | MP0010768_mortality/aging | 0.46703516 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.46675455 |
| 125 | MP0005253_abnormal_eye_physiology | 0.46376593 |
| 126 | MP0010769_abnormal_survival | 0.46164710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.96745546 |
| 2 | Neurofibrillary tangles (HP:0002185) | 5.13005546 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.08611771 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.08611771 |
| 5 | Focal motor seizures (HP:0011153) | 4.98927551 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.97520314 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.58048397 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.34308811 |
| 9 | Ankle clonus (HP:0011448) | 4.20546598 |
| 10 | Action tremor (HP:0002345) | 4.19315602 |
| 11 | Dysmetria (HP:0001310) | 3.94092327 |
| 12 | Spastic gait (HP:0002064) | 3.90161479 |
| 13 | Intention tremor (HP:0002080) | 3.86744237 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.85338553 |
| 15 | Focal seizures (HP:0007359) | 3.83318077 |
| 16 | Insidious onset (HP:0003587) | 3.60638337 |
| 17 | Termporal pattern (HP:0011008) | 3.60638337 |
| 18 | Atonic seizures (HP:0010819) | 3.55431472 |
| 19 | Scanning speech (HP:0002168) | 3.39463125 |
| 20 | Onion bulb formation (HP:0003383) | 3.37895959 |
| 21 | Sensory axonal neuropathy (HP:0003390) | 3.27923914 |
| 22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.18539309 |
| 23 | Urinary urgency (HP:0000012) | 3.18320534 |
| 24 | Cerebral hypomyelination (HP:0006808) | 3.09699683 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.07672546 |
| 26 | Bell-shaped thorax (HP:0001591) | 3.02266924 |
| 27 | Postural instability (HP:0002172) | 2.98869519 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.94806182 |
| 29 | Visual hallucinations (HP:0002367) | 2.93179685 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.85764650 |
| 31 | Abnormal auditory evoked potentials (HP:0006958) | 2.84780714 |
| 32 | Bundle branch block (HP:0011710) | 2.81586111 |
| 33 | Alacrima (HP:0000522) | 2.81423174 |
| 34 | Slow saccadic eye movements (HP:0000514) | 2.80007517 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.76961203 |
| 36 | Hemiplegia (HP:0002301) | 2.76337568 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71749114 |
| 38 | Broad-based gait (HP:0002136) | 2.67192947 |
| 39 | Lower limb muscle weakness (HP:0007340) | 2.67039367 |
| 40 | Pheochromocytoma (HP:0002666) | 2.62771613 |
| 41 | Stridor (HP:0010307) | 2.59960462 |
| 42 | Megalencephaly (HP:0001355) | 2.59756370 |
| 43 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.59285472 |
| 44 | Increased circulating renin level (HP:0000848) | 2.58214215 |
| 45 | Clonus (HP:0002169) | 2.55664918 |
| 46 | Choreoathetosis (HP:0001266) | 2.48177125 |
| 47 | Anxiety (HP:0000739) | 2.47530938 |
| 48 | Rhinitis (HP:0012384) | 2.46688339 |
| 49 | Tetraplegia (HP:0002445) | 2.45610069 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.41405386 |
| 51 | Generalized tonic-clonic seizures (HP:0002069) | 2.41381709 |
| 52 | Abnormal eating behavior (HP:0100738) | 2.41202163 |
| 53 | Morphological abnormality of the inner ear (HP:0011390) | 2.40829356 |
| 54 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.40626337 |
| 55 | Depression (HP:0000716) | 2.40290298 |
| 56 | Mutism (HP:0002300) | 2.37113515 |
| 57 | Amelogenesis imperfecta (HP:0000705) | 2.37051169 |
| 58 | Papilledema (HP:0001085) | 2.35950752 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.34065496 |
| 60 | Akinesia (HP:0002304) | 2.32289729 |
| 61 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32218335 |
| 62 | Dialeptic seizures (HP:0011146) | 2.31329596 |
| 63 | Status epilepticus (HP:0002133) | 2.30897046 |
| 64 | Hyperaldosteronism (HP:0000859) | 2.30537645 |
| 65 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29884836 |
| 66 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29884836 |
| 67 | Aplasia involving bones of the extremities (HP:0009825) | 2.29884836 |
| 68 | Absent speech (HP:0001344) | 2.28943612 |
| 69 | Torticollis (HP:0000473) | 2.27301774 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.24142841 |
| 71 | Decreased lacrimation (HP:0000633) | 2.20952815 |
| 72 | Absence seizures (HP:0002121) | 2.19529755 |
| 73 | Bowel incontinence (HP:0002607) | 2.18392440 |
| 74 | Hemiparesis (HP:0001269) | 2.17210803 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.16568354 |
| 76 | Premature skin wrinkling (HP:0100678) | 2.16385729 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.15548657 |
| 78 | Truncal ataxia (HP:0002078) | 2.15027074 |
| 79 | Febrile seizures (HP:0002373) | 2.14545491 |
| 80 | Retinal dysplasia (HP:0007973) | 2.14265262 |
| 81 | Abnormal ciliary motility (HP:0012262) | 2.13504259 |
| 82 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.12813137 |
| 83 | Absent/shortened dynein arms (HP:0200106) | 2.12813137 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 2.12493616 |
| 85 | Clumsiness (HP:0002312) | 2.09897336 |
| 86 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.09584200 |
| 87 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.09584200 |
| 88 | Abnormality of saccadic eye movements (HP:0000570) | 2.09551362 |
| 89 | Sleep apnea (HP:0010535) | 2.08395716 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07690496 |
| 91 | Chronic bronchitis (HP:0004469) | 2.06079457 |
| 92 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.05313188 |
| 93 | Annular pancreas (HP:0001734) | 2.03613247 |
| 94 | Hammertoe (HP:0001765) | 2.02723349 |
| 95 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.02432410 |
| 96 | Leukodystrophy (HP:0002415) | 1.99950988 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99904102 |
| 98 | Abnormal large intestine physiology (HP:0012700) | 1.99728582 |
| 99 | Hyperactive renin-angiotensin system (HP:0000841) | 1.99651498 |
| 100 | Postural tremor (HP:0002174) | 1.99472765 |
| 101 | Abnormality of binocular vision (HP:0011514) | 1.98686040 |
| 102 | Diplopia (HP:0000651) | 1.98686040 |
| 103 | Poor eye contact (HP:0000817) | 1.97891352 |
| 104 | Delusions (HP:0000746) | 1.96625932 |
| 105 | Apathy (HP:0000741) | 1.95182199 |
| 106 | CNS hypomyelination (HP:0003429) | 1.95076803 |
| 107 | Cerebral hemorrhage (HP:0001342) | 1.94125736 |
| 108 | Spastic tetraparesis (HP:0001285) | 1.93300292 |
| 109 | Impaired smooth pursuit (HP:0007772) | 1.92987050 |
| 110 | Progressive inability to walk (HP:0002505) | 1.92857753 |
| 111 | Confusion (HP:0001289) | 1.92726696 |
| 112 | Abnormal social behavior (HP:0012433) | 1.92419093 |
| 113 | Impaired social interactions (HP:0000735) | 1.92419093 |
| 114 | Blue irides (HP:0000635) | 1.92256443 |
| 115 | Slow progression (HP:0003677) | 1.89893166 |
| 116 | Focal dystonia (HP:0004373) | 1.89768568 |
| 117 | Gait ataxia (HP:0002066) | 1.84332417 |
| 118 | Distal sensory impairment (HP:0002936) | 1.84230012 |
| 119 | Parakeratosis (HP:0001036) | 1.84032986 |
| 120 | Limb dystonia (HP:0002451) | 1.82706106 |
| 121 | Craniofacial dystonia (HP:0012179) | 1.81969608 |
| 122 | Rigidity (HP:0002063) | 1.81681097 |
| 123 | Foot dorsiflexor weakness (HP:0009027) | 1.79397084 |
| 124 | Hypomagnesemia (HP:0002917) | 1.77204635 |
| 125 | Fetal akinesia sequence (HP:0001989) | 1.76701937 |
| 126 | Hypokalemic alkalosis (HP:0001949) | 1.75123887 |
| 127 | Spastic paraparesis (HP:0002313) | 1.73156739 |
| 128 | Decreased motor nerve conduction velocity (HP:0003431) | 1.70721890 |
| 129 | Abnormality of the periventricular white matter (HP:0002518) | 1.70654278 |
| 130 | Bradykinesia (HP:0002067) | 1.69622912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYRO3 | 4.28298755 |
| 2 | STK39 | 3.53609531 |
| 3 | EPHA4 | 3.48388187 |
| 4 | FES | 3.35784134 |
| 5 | TNIK | 3.14881638 |
| 6 | OXSR1 | 2.62022429 |
| 7 | UHMK1 | 2.45804262 |
| 8 | NTRK3 | 2.35903719 |
| 9 | MARK1 | 2.06540492 |
| 10 | NTRK1 | 2.03144946 |
| 11 | WNK1 | 2.00568960 |
| 12 | EPHB1 | 1.98053828 |
| 13 | MAP3K9 | 1.94516208 |
| 14 | PAK6 | 1.92595871 |
| 15 | MINK1 | 1.84308428 |
| 16 | PKN1 | 1.80141820 |
| 17 | CASK | 1.70063459 |
| 18 | LIMK1 | 1.68392531 |
| 19 | KSR2 | 1.65310427 |
| 20 | RIPK1 | 1.59446082 |
| 21 | CDK19 | 1.59028725 |
| 22 | NTRK2 | 1.58849656 |
| 23 | ICK | 1.57003235 |
| 24 | PINK1 | 1.50998660 |
| 25 | MAPKAPK5 | 1.49262475 |
| 26 | MAP3K4 | 1.48039911 |
| 27 | PRKD3 | 1.47360090 |
| 28 | WNK4 | 1.46442561 |
| 29 | NEK6 | 1.35356560 |
| 30 | CAMKK2 | 1.32302327 |
| 31 | IRAK2 | 1.26800184 |
| 32 | ROCK2 | 1.25567628 |
| 33 | CDK5 | 1.25457179 |
| 34 | PNCK | 1.25394598 |
| 35 | PRPF4B | 1.24953033 |
| 36 | MAPK13 | 1.24355152 |
| 37 | SGK223 | 1.20707889 |
| 38 | SGK494 | 1.20707889 |
| 39 | CAMK2B | 1.17322680 |
| 40 | PHKG2 | 1.17179042 |
| 41 | PHKG1 | 1.17179042 |
| 42 | MAP3K2 | 1.12669993 |
| 43 | FGFR2 | 1.12559428 |
| 44 | PDGFRB | 1.11174411 |
| 45 | BCR | 1.02046072 |
| 46 | DAPK2 | 0.97225941 |
| 47 | MARK2 | 0.96253643 |
| 48 | CAMKK1 | 0.95716216 |
| 49 | SGK2 | 0.95645955 |
| 50 | CAMK2D | 0.95422064 |
| 51 | FGR | 0.94668923 |
| 52 | SIK2 | 0.90760635 |
| 53 | PRKCH | 0.89543207 |
| 54 | MAP2K7 | 0.88445686 |
| 55 | CAMK2A | 0.86346955 |
| 56 | CAMK2G | 0.84574799 |
| 57 | PAK3 | 0.84412270 |
| 58 | CDK14 | 0.80649032 |
| 59 | ARAF | 0.80142033 |
| 60 | MAP3K13 | 0.80017940 |
| 61 | DAPK1 | 0.79873437 |
| 62 | CDK15 | 0.76982004 |
| 63 | FYN | 0.75920026 |
| 64 | SGK3 | 0.75681448 |
| 65 | RIPK4 | 0.75361840 |
| 66 | PDPK1 | 0.75344632 |
| 67 | CSNK1G2 | 0.75155981 |
| 68 | TESK2 | 0.74275689 |
| 69 | CDK18 | 0.72880698 |
| 70 | DYRK1A | 0.71074930 |
| 71 | MUSK | 0.70678428 |
| 72 | PIK3CA | 0.69469189 |
| 73 | MAPK15 | 0.68797165 |
| 74 | MET | 0.68574914 |
| 75 | MAPK12 | 0.68447319 |
| 76 | GRK5 | 0.68115519 |
| 77 | MAP2K4 | 0.67718035 |
| 78 | CDK11A | 0.67430201 |
| 79 | PRKCZ | 0.67392572 |
| 80 | PRKCQ | 0.67156170 |
| 81 | ALK | 0.65497929 |
| 82 | CSNK1G3 | 0.64945511 |
| 83 | PRKD1 | 0.64531803 |
| 84 | LATS2 | 0.64326875 |
| 85 | KSR1 | 0.63875513 |
| 86 | PLK2 | 0.63849579 |
| 87 | RET | 0.63817209 |
| 88 | STK11 | 0.63408096 |
| 89 | PRKCG | 0.63142815 |
| 90 | CSK | 0.61326503 |
| 91 | ROCK1 | 0.61094568 |
| 92 | LMTK2 | 0.60536409 |
| 93 | CSNK1A1L | 0.57240560 |
| 94 | CAMK4 | 0.57042411 |
| 95 | PDK1 | 0.55185718 |
| 96 | ERBB2 | 0.54887929 |
| 97 | PRKCE | 0.53833167 |
| 98 | MAP3K12 | 0.51725504 |
| 99 | PRKCA | 0.50913388 |
| 100 | SGK1 | 0.48215808 |
| 101 | IRAK1 | 0.47212727 |
| 102 | PBK | 0.46331718 |
| 103 | JAK1 | 0.46325027 |
| 104 | TNK2 | 0.44282373 |
| 105 | STK38 | 0.43807830 |
| 106 | PRKG2 | 0.42938940 |
| 107 | CAMK1 | 0.42784738 |
| 108 | MAPK10 | 0.42083910 |
| 109 | DDR2 | 0.41912914 |
| 110 | PRKG1 | 0.41673675 |
| 111 | CAMK1G | 0.41141857 |
| 112 | CLK1 | 0.39128138 |
| 113 | MAP2K1 | 0.39094988 |
| 114 | * RPS6KA3 | 0.38559620 |
| 115 | MAP3K1 | 0.38062613 |
| 116 | CSNK1G1 | 0.37855909 |
| 117 | BMPR2 | 0.36873158 |
| 118 | PRKACA | 0.36679997 |
| 119 | INSR | 0.35691565 |
| 120 | PRKCB | 0.35436673 |
| 121 | DMPK | 0.34839236 |
| 122 | SRC | 0.33959457 |
| 123 | CSNK1A1 | 0.32174081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54323147 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.52383417 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48318533 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.45064832 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.44025721 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41166010 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16765083 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.13361396 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.08147142 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.03786541 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99906507 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94203906 |
| 13 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90582218 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84617406 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.80899154 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.78440038 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77724054 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76703202 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75807258 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 1.75066761 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.70149333 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.67294071 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62450573 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.59357480 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54020111 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51235453 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47904594 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41622889 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33538070 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31761340 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.30326215 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.27860980 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26413296 |
| 34 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23867780 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23265070 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.20387887 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18367900 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17052332 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.16942894 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16028796 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15051301 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13266452 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09287048 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.09149635 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08146409 |
| 46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.08103980 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04004458 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03130610 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02461377 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99430717 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99130576 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98790768 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95265214 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95023924 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94761789 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94584880 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94500105 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91023457 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89902508 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87457102 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86317731 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85236059 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84727144 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84376223 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78423136 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.78148991 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75994749 |
| 68 | Tight junction_Homo sapiens_hsa04530 | 0.75873512 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74950065 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71455398 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71342575 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70073421 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.68453608 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68353449 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66716087 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65970731 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65684460 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65517625 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64419770 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.64097346 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63853631 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63327767 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63079797 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60765727 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59684587 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59502994 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58146914 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57645363 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57520577 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55644360 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54159336 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51888341 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.51791313 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51280980 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.50359226 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.48701451 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47252198 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46866829 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46264057 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.45455076 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44674617 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44360365 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43967118 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43475365 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41983821 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40932959 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40149225 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38733647 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.38332450 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.35732761 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35576856 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34810715 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33750466 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33372756 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33099548 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32462650 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31779584 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30408959 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27542041 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27230840 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24175731 |

